Eversept Partners, LP Neurocrine Biosciences Inc Put Options Transaction History
Eversept Partners, LP
- $904 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NBIX
# of Institutions
649Shares Held
96.9MCall Options Held
800KPut Options Held
565K-
Black Rock Inc. New York, NY14.2MShares$1.9 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.33 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$740 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$650 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$357 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...